These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 34089357)

  • 41. Perplexing pyretic polyarthritis.
    Hanspal RS
    J Miss State Med Assoc; 2010 Apr; 51(4):114-6. PubMed ID: 20827882
    [No Abstract]   [Full Text] [Related]  

  • 42. Monoclonal antibody therapy in COVID-19.
    Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperuricemia and gout. A modern approach to diagnosis and treatment.
    Gall EP
    Postgrad Med; 1979 Apr; 65(4):163-7, 170, 172. PubMed ID: 424348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors.
    Wechalekar MD; Vinik O; Moi JH; Sivera F; van Echteld IA; van Durme C; Falzon L; Bombardier C; Carmona L; Aletaha D; Landewé RB; van der Heijde DM; Buchbinder R
    J Rheumatol Suppl; 2014 Sep; 92():15-25. PubMed ID: 25180124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of patients with Behçet's disease during the COVID-19 pandemic.
    Dursun R; Temiz SA; Özer İ; Daye M; Ataseven A
    Dermatol Ther; 2020 Nov; 33(6):e14063. PubMed ID: 32710599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SARS-CoV-2 and its relationship with the genitourinary tract: Implications for male reproductive health in the context of COVID-19 pandemic.
    Hallak J; Teixeira TA; Bernardes FS; Carneiro F; Duarte SAS; Pariz JR; Esteves SC; Kallas E; Saldiva PHN
    Andrology; 2021 Jan; 9(1):73-79. PubMed ID: 32869939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new perspective on the pharmacoeconomics of colchicine.
    Wertheimer AI; Davis MW; Lauterio TJ
    Curr Med Res Opin; 2011 May; 27(5):931-7. PubMed ID: 21370937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colchicine in Gout: An Update.
    Pascart T; Richette P
    Curr Pharm Des; 2018; 24(6):684-689. PubMed ID: 29336252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.
    Contoli M; Papi A; Tomassetti L; Rizzo P; Vieceli Dalla Sega F; Fortini F; Torsani F; Morandi L; Ronzoni L; Zucchetti O; Pavasini R; Fogagnolo A; Volta CA; Bartlett NW; Johnston SL; Spadaro S; Campo G
    Front Immunol; 2021; 12():648004. PubMed ID: 33767713
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperuricemia and gout.
    Lo B
    West J Med; 1985 Jan; 142(1):104-7. PubMed ID: 3976216
    [No Abstract]   [Full Text] [Related]  

  • 54. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
    Pinheiro MM; Fabbri A; Infante M
    Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SARS-CoV-2-specific virulence factors in COVID-19.
    Kumar A; Prasoon P; Kumari C; Pareek V; Faiq MA; Narayan RK; Kulandhasamy M; Kant K
    J Med Virol; 2021 Mar; 93(3):1343-1350. PubMed ID: 33085084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of acute gout: a systematic review.
    Khanna PP; Gladue HS; Singh MK; FitzGerald JD; Bae S; Prakash S; Kaldas M; Gogia M; Berrocal V; Townsend W; Terkeltaub R; Khanna D
    Semin Arthritis Rheum; 2014 Aug; 44(1):31-8. PubMed ID: 24650777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gout and the COVID-19 pandemic.
    Tai V; Robinson PC; Dalbeth N
    Curr Opin Rheumatol; 2022 Mar; 34(2):111-117. PubMed ID: 34907115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-inflammatory therapy for COVID-19 infection: the case for colchicine.
    Reyes AZ; Hu KA; Teperman J; Wampler Muskardin TL; Tardif JC; Shah B; Pillinger MH
    Ann Rheum Dis; 2021 May; 80(5):550-557. PubMed ID: 33293273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Familial Mediterranean Fever and COVID-19: Friends or Foes?
    Stella A; Lamkanfi M; Portincasa P
    Front Immunol; 2020; 11():574593. PubMed ID: 33072117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Update on colchicine and its mechanism of action.
    Molad Y
    Curr Rheumatol Rep; 2002 Jun; 4(3):252-6. PubMed ID: 12010611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.